US2015240288A1PendingUtilityA1
Lyophilised dabigatran
Est. expiryFeb 2, 2029(~2.5 yrs left)· nominal 20-yr term from priority
Inventors:Joachim Stangier
A61P 7/02A61K 31/4439G01N 2496/45C12Q 1/56A61K 9/19G01N 2496/00G01N 2333/974G01N 33/96G01N 33/94G01N 2430/00
24
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention relates to a lyophilised form of dabigatran of formula I its use as a calibrator in the assays for the determination of pharmacodinamic effects of dabigatran etexilate as well as such assays per se.
Claims
exact text as granted — not AI-modified1 - 4 . (canceled)
5 . The lyophilized dabigatran made by the process comprising the steps of:
(1) dissolving dabigatran in 1M HCl and diluting with purified water to make a dabigatran stock solution, (2) diluting aliquots of dabigatran stock solution with human anticoagulated plasma to provide final solutions having different nanomolar concentrations of dabigatran, wherein the human anticoagulated plasma is human citrated plasma or EDTA-anticoagulated plasma, and (3) freeze-drying aliquots of the thus obtained final solutions to be used as lyophilized calibrator agents or lyophilized calibrator agents in an anticoagulant assay, optionally storing lyophilized calibrators at −20 ° C.
6 . The lyophilized dabigatran according to claim 5 , wherein the lyophilised dabigatran is used as a calibrator agent or a calibrator agent in an anticoagulation assay.
7 - 10 . (canceled)
11 . A kit for the determination of the concentration of dabigatran in a blood sample consisting of an assay for the determination of the concentration of dabigatran in a blood sample together with lyophilised dabigatran according to claim 5 .
12 . The kit according to claim 11 wherein the assay for the determination of the concentration of dabigatran in a blood sample comprises a reagent 1 which is human anticoagulated plasma and a reagent 2 which comprises highly purified human thrombin in the a form.
13 . The kit according to claim 11 wherein reagent 1 and reagent 2 are lyophilised.
14 - 15 . (canceled)
16 . The lyophilized dabigatran according to claim 5 , wherein the lyophilised dabigatran is used to determine the accuracy of an assay or an anticoagulation assay.Join the waitlist — get patent alerts
Track US2015240288A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.